Tuesday, February 7, 2023


Biotechnology News Magazine

Laura Mantell Joins Iterative Scopes as Vice President of Life Sciences

Latest Posts

Nectin Therapeutics to Collaborate with Merck on Clinical Trial of Anti-PVR Antibody NTX1088 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced and...

NTX1088 is a First-in-Class and highly potent monoclonal antibody directed against PVR (CD155), a transmembrane protein expressed on cancer cells and associated with resistance to PD1 and PDL1 immune checkpoint inhibitors.

TransCure bioServices Offers BioVolume 3D Imaging for Insightful Preclinical Oncology Research

BioVolume reconstructs tumors from 3D, RGB, and thermal imaging. The solution is non-invasive, using a machine learning algorithm to automatically calculate subcutaneous tumor length, height, and width.

CLINUVEL Drug Significantly Reduces UV Skin Damage

“Today’s results build upon the decades of research CLINUVEL has conducted into the use of afamelanotide to protect skin from light, with the first evidence that a single dose of the drug has a photoprotective effect in healthy volunteers. These data add to our regulatory dossier for XP while further developing our specialised healthcare products for wider populations at highest risk of UV-induced damage and skin cancer,” Dr Bilbao said.

Deciphex Completes Validation Activities Enabling Veterinary Consultant Pathologists to Perform CLP Peer Review Digitally Using Patholytix

GLP and non-GLP studies can now be digitally peer reviewed by consultant pathologists for CROs and Pharma companies leading to faster study review and reduced backlogs with Drug candidates brought to clinical trials sooner advises Deciphex.

Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that Laura Mantell has joined its leadership team as Vice President of Life Sciences.

“Laura Mantell brings to us a wealth of experience in the healthtech space, having spent the last decade leading and growing some of the most impactful startups in healthcare,” said Jonathan Ng, founder and CEO of Iterative Scopes. “Having gotten to know Laura over the past year, I know that she not only brings onboard deep knowledge of the healthcare industry, but is also a great fit for the culture and team that we are building here at Iterative Scopes.”

As Vice President of Life Sciences at Iterative Scopes, Laura Mantell will steer all life sciences, biopharma, and biotech partnerships—including new, existing, and growing business. She will play a critical role in Iterative Scopes’ work to optimize clinical trials, advance therapies to market, and improve patient outcomes.

Prior to joining Iterative Scopes, Laura Mantell led the digital health team at Ribbon Health, a series-B startup building an API layer for healthcare enterprises. Before that, she was a Principal at Flatiron Health (now a member of the Roche Group), where she helped build and scale the life sciences organization as an early member of the team.

“Iterative Scopes is leading the way in a new and growing space, and I’m so excited to join the team,” says Laura Mantell. “This position and organization offer a tremendous new opportunity to use technology to increase recruitment for clinical trials, streamline provider workflows, and improve patient care. I look forward to partnering with providers, EHR systems, and life sciences companies, as well as working with my Iterative Scopes colleagues, to generate important insights that will accelerate drug development and R&D in the field.”

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine